HomepageSTAR • NSE
add
Strides Pharma Science Ltd
Vorige slotkoers
₹ 1.643,30
Dag-range
₹ 1.593,55 - ₹ 1.654,95
Jaar-range
₹ 467,00 - ₹ 1.675,00
Beurswaarde
149,79Â mld. INR
Gem. volume
349,47K
Koers/winst
3.343,12
Dividendrendement
0,15%
Primaire beurs
NSE
Marktnieuws
.INX
0,40%
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
(INR) | jun 2024info | Wijziging j-o-j |
---|---|---|
Opbrengst | 10,88Â mld. | 16,94% |
Bedrijfskosten | 4,99Â mld. | 13,84% |
Netto inkomsten | 702,02Â mln. | 1.086,95% |
Netto winstmarge | 6,46 | 950,00% |
Winst per aandeel | — | — |
EBITDA | 2,24Â mld. | 33,22% |
Effectief belastingtarief | 19,80% | — |
Balans
Totale activa
Totale passiva
(INR) | jun 2024info | Wijziging j-o-j |
---|---|---|
Contanten en kortetermijnbeleggingen | 2,97Â mld. | -19,05% |
Totale activa | — | — |
Totale passiva | — | — |
Totaal aandelenvermogen | 20,72 mld. | — |
Uitstaande aandelen | 91,89 mln. | — |
Koers-boekwaardeverhouding | 7,10 | — |
Rendement op activa | — | — |
Rendement op kapitaal | 9,17% | — |
Kasstroom
Nettomutatie in liquide middelen
(INR) | jun 2024info | Wijziging j-o-j |
---|---|---|
Netto inkomsten | 702,02Â mln. | 1.086,95% |
Operationele kasstroom | — | — |
Kasstroom uit beleggingen | — | — |
Kasstroom uit financiering | — | — |
Nettomutatie in liquide middelen | — | — |
Vrije kasstroom | — | — |
Over
Strides Pharma Science Limited is an Indian pharmaceutical company, headquartered at Bangalore in southern India. The company manufactures pharmaceutical products, over-the-counter drugs and nutraceuticals. Products include softgel capsules, hard-gel capsules, tablets and dry and wet injectables. Its softgel manufacturing capability consists of an annual capacity of 50,000 machine hours or about three billion softgel capsules. The company has 15 manufacturing sites in six countries and marketing presence in 50 countries. In the United States and Canadian markets, the company partners with generic companies to supply retail and hospital generics in injectable products and softgels. In European markets, it has long-term relationships for the development of projects and supply agreements with the European companies. In Australia and New Zealand, the company is engaged in manufacturing and supply of soft gels and value-added manufacturing. The company has development and supply agreements with South African companies. The company's stock trades on the Bombay Stock Exchange and on the National Stock Exchange of India. Wikipedia
Opgericht
1990
Hoofdvestiging
Website
Werknemers
3.065